KDM4B deficiency enriches promoter H3K36me3 to sustain breast cancer stemness [23], while SUMOylated NRF2 (K110) transcriptionally activates PHGDH to bolster antioxidant defenses in HCC [27]. Here, PHGDH is linked to breast cancer.